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Objective: The recommendations of the American Institute of Medicine (IOM) were revised recently in
order to enhance maternal and neonatal health. The aim of our study was to investigate the risk of low
birth weight (LBW) among women who follow the IOM recommendations.
Materials and methods: Gestational weight gain (GWG) and rate of weight gain (RWG) across the
different periods of pregnancy among women who delivered LBW fetuses were analyzed retrospectively.
The logistic regression was used to analyze the risk of LBW and to identify recommendations.
Results: From January 2008 to December 2009, 117 out of 4924 (2.4%) women delivered term LBW fe-
tuses. After exclusions, 88 LBW and 91 control subjects were enrolled into the study. There was increased
risk of cesarean delivery [odds ratio (OR) with 95% conﬁdence interval (CI): 2.53 (1.33e4.83)] and
neonatal asphyxia within 7 days of birth [OR 95% CI: 5.71 (1.21e26.83)] for the LBW group compared
with the control group. Normal weight women [body mass index (BMI): 18.5e24.9 kg/m2] who followed
the GWG and RWG recommendations of the IOM had no increased risk of LBW. However, there was a
two-to three-fold increased LBW risk among normal weight women who followed the IOM guidelines
when, during the 2nd trimester, their GWG was 7 kg [OR 95% CI: 2.21 (1.28e6.49)] or their RWG was
0.45 kg/week [OR 95% CI: 3.14 (1.32e7.47)]. Among underweight women (BMI < 18.5 kg/m2), if, during
the 2nd and 3rd trimesters, they followed the lower range of the GWG and RWG recommendations of the
IOM there was a ﬁve-fold increased risk of LBW if the GWG was 13 kg [OR 95% CI: 5.29 (1.61e25.51)]; or
the RWG was 0.45 kg/week [OR 95% CI: 5.35 (1.61e24.66)].
Conclusion: For underweight women, it is suggested that they follow the upper range of the IOM
recommendation in order to avoid LBW. For normal weight women, although the IOM guidelines provide
a good basis, it is suggested that they carefully follow the recommended GWG and the RWG values
during the 2nd trimester, which is a very important period for fetal growth.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Newborns with a birth weight of less than 2500 g (low birth
weight, LBW) have an increased risk of perinatal morbidity and
mortality [1e3]. Increased adulthood hypertension and moreand Gynecology, Shin Kong
hang Road, Shin Lin, Taipei,
eow).
bstetrics & Gynecology. Publishedfrequent type 2 diabetes are also found among these LBW infants
during their later life [4,5]. The causes of LBW include fetal,
placental, andmaternal factors and examples include chromosomal
abnormality, placenta previa, maternal hypertension, and inap-
propriate nutrition [6]. To enhance the status of the neonate and
the baby's later health, it is important that LBW is avoided. Knowing
the variables that affect fetal growth is important and may provide
the physician with a reference point when carrying out patient
consultation; this will help to limit unfavorable outcomes. Recently,
a systemic review has indicated that there is strong evidenceby Elsevier Taiwan LLC. All rights reserved.
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gain (GWG) and decreased birth weight as well as with poor fetal
growth [7]. A study from Stotland et al [8] has also suggested that a
low GWG is associated with a neonate being small for their gesta-
tional age. Clinically, an optimal GWG seems to be critical to having
a favorable birth weight and good maternal health. However, the
question remains as to what is an optimal GWG that is able to
prevent LBW. In 2009, the American Institute of Medicine (IOM) set
recommendations for total GWG based on prepregnancy bodymass
index (BMI) [9]. They emphasized that physicians ought to advise
patients about what is the appropriate amount of weight that
should be gained during pregnancy [9 e11]. The recommendations
were as follows: (1) 28e40 lbs for underweight womenwith a BMI
less than 18.5 kg/m2; (2) 25e35 lbs for women with normal BMI
(18.5e24.9 kg/m2); (3) 15e25 lbs for women with high BMI
(25.0e29.9 kg/m2); and (4) 11e20 lbs for obese women
(BMI > 30.0 kg/m2) [10]. The BMI ranges in the document for each
weight category were slightly different from previous recommen-
dations [10,11]. In addition to recommending target GWG values,
they also recommended the rate of weight gain (RWG) as follows: 1
(1.0e1.3) lbs/week for underweight individuals, 1 (0.8e1.0) lbs/
week for normal weight individuals, 0.6 (0.5e0.7) lbs/week for
overweight individuals, and 0.5 (0.4e0.6) lbs/week for obese in-
dividuals. These guidelines are believed to minimize the negative
health consequences for both mother and fetus of either inade-
quate or excessive weight gain [10,11]. To our knowledge, there is
no study at present that has examined the guidelines for women
who deliver a LBW fetus. The aim of this study is to investigate the
association of LBW/GWG and LBW/RWG relationships in terms of
the recommendations of the IOM. The relationship between GWG
during different periods of gestation and the risk of LBW are also
investigated in this study together with the detected adverse
obstetrical outcomes associated with LBW.
Materials and methods
The medical records of women who had delivered fetuses after
37 weeks of gestation with a birth weight of less than 2500 g be-
tween January 2008 and December 2009 in our hospital were
reviewed retrospectively. Age (years), gestational length (weeks),
parity, body height (cm), initial body weight (kg), and weight at
every antenatal attendance until birth (kg) were recorded. The
GWG (kg) was calculated as the maternal weight at birth minus the
initial weight. The RWG during the 2nd and 3rd trimesters (kg/week)
were calculated as (weight at birth minus weight at 12 weeks)/
(gestational week at birth minus 12). The RWG during the 2nd
trimester was calculated as (weight at 28 weeks minus weight at 12
weeks)/16. The RWG during the 3rd trimester was calculated as
(weight at birth minus weight at 28 weeks)/(gestational week at
birth minus 28 weeks). The placenta weight (g), blood loss at birth
(mL), mode of delivery, the indications re cesarean section, birth
body weight (BBW) (g), birth body length (BBL) (cm), the Apgar
score at 1 minute, and the Apgar score at 5 minutes were also
recorded. Newborns that were sent to the neonatal intensive care
unit (NICU) due to asphyxia within 7 days of birth were also noted.
The initial maternal body weight was deﬁned as the body weight
before pregnancy or the weight before 8 weeks of gestation as
recorded by the physician. Data from pregnant women with
matched prepregnancy BMIs were used as the control subjects. BMI
was calculated as weight (in kg) divided by height (in m) squared
(kg/m2). The BMI increase was deﬁned as the difference between
BMI at birth and the prepregnancy BMI. We deﬁned the 2nd
trimester as the period from the 13th to the 28th gestational week
and the 3rd trimester as the period from the 29th gestational week
to birth.An examination of the IOM recommendations, including the
range of target weight gains across the different categories of BMI,
was carried out. There were a limited number of overweight and
obesewomen included in this study and thereforewe only used the
IOM guidelines for normal weight and underweight women. The
GWG and RWG values for the separated 2nd and 3rd trimesters were
also investigated. The reference weight gain for the 2nd trimester
was set as the RWGmultiplied by 16weeks and for the 3rd trimester
as the RWG multiplied by 12 weeks. We also stratiﬁed the 2nd
trimester into two periods, namely 13e20 weeks of gestation and
21e28 weeks of gestation. The GWG values over these two periods
were also calculated.
Statistical analysiswas performedusing SPSS software (SPSS Inc.,
Chicago, IL, USA). The t test was used to compare differences be-
tween the two groups for gestational weeks, body height, initial
bodyweight,weight at birth,GWG,blood loss amount at birth, initial
BMI, and BMI at birth. TheManneWhitney testwas used to compare
the difference in age. The Chi-square test was used to compare dif-
ferences in cesarean rate and NICU rate. Logistic regression analysis
wasused to analyze the riskof LBWin the studyand the results of the
logistic regressionwere expressed as odds ratios (ORs) including the
corresponding 95% conﬁdence intervals (CIs). The LBW ORs for the
normal weight and underweight groups that werewithin the range
of the IOM recommendations were estimated. In addition, we also
calculated the LBWORswith reference to GWG and RWG separately
for the 2nd trimester, 3rd trimester, 13e20 weeks of gestation and
21e28 weeks of gestation. The LBW ORs using gestational length
stratiﬁcation for week after the 37th week of pregnancy were also
calculated. All the ORs were adjusted for age. A p value of <0.05 was
considered statistically signiﬁcant.
Results
Basic characteristics and the differences between the LBW group and
the control group
In total, 117 womenwho delivered a singleton term fetus whose
birth weight was less than 2500 g (LBW) were enrolled in this
study. We excluded 12 subjects with preeclampsia, 10 women who
had been referred from other clinics and had incomplete antenatal
records, and seven women with various medical diseases that may
bias the results (5 diabetic pregnancies, 1 chronic renal failure, 1
congenital heart disease). Therefore, the data from the records of 88
LBW and 91 control subjects were analyzed. Over this time, 4924
fetuses were delivered at our hospital, so the LBW incidence was
2.4%. Table 1 presents the basic characteristics of the studied sub-
jects. The percentage of underweight, normal weight, and over-
weight women in the LBW group was 21.9%, 67.1%, and 11.0%,
respectively. The results revealed that there is a higher female baby
ratio in the LBW group than the control group (60.2% vs. 48.4%);
however, this difference was not statistically signiﬁcant by the Chi-
square test (p ¼ 0.11). When Table 2 is examined, the average
gestational length in weeks can be seen to be signiﬁcantly different
between the two groups (38.16 ± 1.17 vs. 39.02 ± 1.13, p < 0.0001).
However, there was no difference in average body height
(157.99 ± 5.38 vs. 158.91 ± 5.49 cm), initial weight (52.52 ± 9.22 vs.
52.86 ± 6.34 kg), or weight at birth (64.34 ± 9.18 vs. 66.11 ± 7.70 kg)
between the two groups. Nonetheless, the average GWG value in
the LBW group was signiﬁcantly less than that of the control group
(11.61 ± 3.81 vs. 13.49 ± 3.75 kg, p ¼ 0.002). The average initial BMI
and BMI at birth were not signiﬁcantly different between the two
groups, however, the BMI increase was lower for the LBW group
than for the control group (4.56 ± 1.63 vs. 5.25 ± 1.49 kg/m2,
p ¼ 0.006). The average BBW was 2305.40 ± 210.73 g and the
average BBL was 47.12 ± 1.89 cm for the LBW group, while those of
Table 2
The clinical data between the group who gave birth to babies with a birth weight of
less than 2500 g (LBW) and the control group.
LBW (n ¼ 88) Control (n ¼ 91) p*
Age (y) 32.11 ± 4.45 31.73 ± 4.15 0.547
Gestational length (week) 38.16 ± 1.17 39.02 ± 1.13 <0.0001
Body height (cm) 157.99 ± 5.38 158.91 ± 5.49 0.527
Initial body weight (kg) 52.52 ± 9.22 52.86 ± 6.34 0.968
Body weight at birth (kg) 64.34 ± 9.18 66.11 ± 7.70 0.169
GWG (kg) 11.61 ± 3.81 13.49 ± 3.75 0.002
50 g OGTT 120.00 ± 25.46 128.35 ± 24.34 0.033
Placenta weight (g) 535.45 ± 124.56 681.21 ± 145.17 <0.0001
Blood loss at birth (mL) 400.00 ± 346.91 377.68 ± 393.28 0.683
Initial BMI (kg/m2) 21.19 ± 3.61 20.88 ± 2.57 0.532
BMI at birth (kg/m2) 25.77 ± 3.70 26.07 ± 3.06 0.549
BMI increase (kg/m2) 4.56 ± 1.63 5.25 ± 1.49 0.006
Caesarean rate (%)** 43.18 23.08 0.004
Previous caesarean (n) 8 7
Malpresentation 7 4




Cephalo-pelvis disproportion 0 1
Fetal distress 8 0
Contracted pelvis 1 0
Antepartum hemorrhage 6 2
Others 1 0
Blood loss at birth over
1000 mL (%)**
7.95 10.99 0.489
BBW (g) 2305.40 ± 210.73 3161.43 ± 324.67 <0.0001
BBL (cm) 47.12 ± 1.89 50.71 ± 1.87 <0.0001
1 minute Apgar score 8.41 ± 1.25 8.78 ± 0.49 0.001
5 minute Apgar score 8.84 ± 0.98 8.89 ± 0.11 0.163
NICU (%)** 11.36 2.20 0.004
*p < 0.05 is considered as statistically signiﬁcant.
** Compared by c2 test.
BBL ¼ birth body length; BBW ¼ birth body weight; BMI ¼ body mass index;
GWG ¼ gestational weight gain; LBW ¼ low birth weight; NICU ¼ neonatal inten-
sive care unit; OGTT ¼ oral glucose tolerance test.
Table 3
The ORs of adverse obstetric outcomes for fetuses whose birth weights are less than
2500 g in this study (n ¼ 179).
n (%) OR (95% CI) p*
Cesarean delivery 59 (33) 2.53 (1.33e4.83) 0.005
Blood loss at birth over 1000 ml 17 (9.5) 14.29 (0.52e3.94) 0.490
1minute Apgar score <7 12 (6.7) 3.34 (0.87e12.78) 0.078
5 minute Apgar score <7 1 (0.6) 5.49 (0.63e47.57) 0.124
NICU 12 (6.7) 5.71 (1.21e26.83) 0.028
*p < 0.05 was considered statistically signiﬁcant.
CI ¼ conﬁdence interval; NICU ¼ neonatal intensive care unit; OR ¼ odds ratio.
Table 1
Basic characteristics of the studied subjects including 88 fetuses with a birth weight
of less than 2500 g (LBW) and 91 fetuses in the control group.
LBW Control
n (%) n (%)
Age (y)
<20 1 (1.1) 0
21e25 3 (3.4) 6 (6.6)
26e30 30 (34.1) 33 (36.3)
31e35 34 (38.6) 36 (39.6)
36e40 16 (18.1) 14 (15.4)
41e45 4 (4.5) 2 (2.2)
Gestational length (wk)
37 32 (36.4) 3 (3.3)
38 27 (30.7) 33 (36.3)
39 16 (18.2) 26 (28.6)
40 10 (11.4) 19 (20.9)
41 2 (2.3) 8 (8.8)
42 1 (1.1) 2 (2.2)
Parity
0 59 (67.0) 56 (61.5)
1 23 (26.1) 29 (31.9)
>2 6 (6.8) 6 (6.6)
Body height (cm)
<150 10 (11.4) 11 (12.1)
151e155 20 (22.7) 14 (15.4)
156e160 32 (36.4) 28 (30.8)
161e165 18 (20.5) 29 (31.9)
166e170 8 (9.1) 8 (8.8)
171e175 0 1 (1.1)
Body weight (kg)
<40 2 (2.6) 2 (2.2)
41e45 14 (18.2) 9 (9.9)
46e50 22 (28.6) 19 (20.1)
51e55 18 (23.4) 27 (29.7)
56e60 7 (9.1) 24 (26.4)
61e65 8 (10.4) 7 (7.7)




<18.5 (%) 16 (21.9) 18 (19.8)
18.5e24.9 49 (67.1) 67 (73.6)
25.0e29.9 8 (11.0) 6 (6.6)
>30 0 0
Sex of newborn
Female 53 (60.2) 44 (48.4)
Male 35 (39.8) 47 (51.6)
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respectively, which were signiﬁcantly different (p < 0.0001). There
were signiﬁcantly lower average 1-minute Apgar scores (8.41± 1.25
vs. 8.78 ± 0.49, p ¼ 0.001) and higher NICU rates (11.36% vs. 2.20%,
p ¼ 0.004) for the LBW group compared to the control group. By
contrast, there was no signiﬁcant difference in average 5-minute
Apgar scores between the two groups (8.84 ± 0.98 vs. 8.89 ± 0.11,
p ¼ 0.163).
The adverse maternal and neonatal outcomes of LBW
We explored the adverse maternal and neonatal outcomes of
LBW by logistic regression. As shown in Table 3, the OR for cesarean
delivery among women who delivered a LBW fetus was 2.53 (95%
CI: 1.33e4.83) and for blood loss over 1000 mL was 14.29 (95% CI:
0.52e3.94). The ORs for low 1-minute and 5-minute Apgar scores
(<7) among LBW subjects were 3.34 (95% CI: 0.87e12.78) and 5.49
(95% CI: 0.63e47.57), respectively; however, all of these values
were not statistically signiﬁcant (p > 0.05). The risk of LBW fetuses
being sent to the NICU due to asphyxia within 7 days of birth was
5.71-fold higher compared to the control group (OR 5.71, 95% CI:
1.21e26.83).Examination of the IOM recommendations for underweight and
normal weight women over the whole pregnancy and during the 2nd
and 3rd trimesters
As shown in Table 4, the LBWOR for normal weight womenwith
a total GWG of 11 kg was 1.84 (95% CI: 0.85e3.98) and of 16 kg
was 2.21 (95% CI: 0.84e5.81), noting that the IOM recommendation
is 11e16 kg for the whole pregnancy. In the underweight women,
the LBW ORs with a total GWG of 13 and of 18 kg were 5.29 (95%
CI: 1.61e25.51) and 1.67 (95% CI: 0.13e21.54), respectively, noting
that the IOM recommendation is 13e18 kg for the whole preg-
nancy. We used the reference GWG for the 2nd and 3rd trimesters by
multiplying the recommended RWG by 28 weeks, although
not every woman delivered at 40 weeks of gestation (for normal
weight women: 10.10e12.60 kg; for underweight women:
12.60e16.50 kg). For normal weight women, the LBW OR for GWG
during the 2nd and 3rd trimesters for 10 kg was 2.12 (95% CI:
0.90e5.01) and for 13 kg was 1.78 (95% CI: 0.81e3.91). Similarly,
Table 4
The aORs for a birth weight less than 2500 g described by GWG and RWG for the whole pregnancy and the 2nd and 3rd trimesters as recommended by the IOM for normal
weight women (BMI 18.5e24.8 kg/m2) and for underweight women (BMI < 18.5 kg/m2).
Normal weight women (n ¼ 115) Underweight women (n ¼ 34)
n (%) aOR (95% CI) p* n (%) aOR (95% CI) p*
In the whole pregnancy
GWG (kg) GWG (kg)
11 44 (38.3) 1.84 (0.85e3.98) 0.12 13 21 (61.8) 5.29 (1.61e25.51) 0.04
16 90 (78.3) 2.21 (0.84e5.81) 0.11 18 31 (91.2) 1.67 (0.13e21.54) 0.69
In the 2nd and 3rd trimester
GWG (kg)a GWG (kg)b
10 31 (27.0) 2.12 (0.90e5.01) 0.09 13 20 (58.8) 6.12 (1.23e30.30) 0.03
13 61 (53.0) 1.78 (0.81e3.91) 0.15 16.5 27 (79.4) 0.74 (011e5.23) 0.76
RWG (kg/wk) RWG (kg/wk)
0.36 26 (22.6) 1.99 (0.81e4.89) 0.13 0.45 14 (41.2) 5.35 (1.61e24.66) 0.03
0.45 52 (45.2) 1.26 (0.58e2.78) 0.55 0.59 26 (76.5) 1.27 (0.23e6.95) 0.79
In the 2nd trimester
GWG (kg)c GWG (kg)d
6 27 (23.5) 3.49 (1.35e9.01) 0.01 7 12 (35.3) 15.84 (2.46e101.99) 0.04
7 48 (41.7) 2.21 (1.28e6.49) 0.01 9 23 (67.6) 2.06 (0.36e11.86) 0.42
RWG (kg/wk) RWG (kg/wk)
0.36 27 (23.5) 3.49 (1.35e9.01) 0.01 0.45 9 (26.5) 7.39 (1.16e46.98) 0.02
0.45 33 (28.7) 3.14 (1.32e7.47) 0.01 0.59 26 (76.5) 2.33 (0.50e10.79) 0.28
In the 3rd trimester
GWG (kg)e GWG (kg)f
4 49 (42.6) 1.56 (0.73e3.32) 0.25 5 22 (64.7) 0.96 (0.22e4.17) 0.96
5 68 (59.1) 1.09 (0.50e2.38) 0.83 7 31 (91.2) 0.77 (0.04e13.63) 0.86
RWG (kg/wk) RWG (kg/wk)
0.36 34 (29.6) 1.55 (0.68e3.49) 0.36 0.45 18 (52.9) 1.00 (0.24e0.41) 1.00
0.45 59 (51.3) 2.73 (0.60e2.70) 0.53 0.59 29 (85.3) 2.73 (0.25e29.60) 0.49
13e20 weeks of gestation
GWG (kg)g GWG (kg)h
3 59 (51.3) 2.60 (1.17e5.77) 0.02 3 14 (41.2) 1.04 (0.84e1.29) 0.71
4 79 (68.7) 7.10 (2.25e22.42) 0.046 4 22 (64.7) 4.26 (0.69e26.20) 0.12
5 95 (82.6) 2.61 (0.66e10.27) 0.17 5 24 (70.6) 2.76 (0.36e20.99) 0.33
RWG (kg/wk) RWG (kg/wk)
0.36 42 (36.5) 3.37 (1.50e7.61) <0.01 0.45 17 (50.0) 3.59 (0.79e16.31) 0.10
0.45 66 (57.4) 3.95 (1.67e9.38) <0.01 0.59 23 (67.6) 3.36 (0.52e21.66) 0.20
21e28 weeks of gestation
GWG (kg)g GWG (kg)h
3 25 (21.7) 1.22 (0.49e3.07) 0.67 3 3 (8.8) NA
4 51 (44.3) 1.52 (0.70e3.32) 0.29 4 18 (52.9) 1.78 (0.39e8.13) 0.46
5 82 (71.3) 0.78 (0.34e1.83) 0.57 5 26 (76.5) 2.76 (0.36e20.99) 0.33
RWG (kg/wk) RWG (kg/wk)
0.36 18 (15.7) 1.33 (0.47e3.72) 0.59 0.45 7 (20.6) 13.02 (1.30e130.50) 0.03
0.45 33 (28.7) 1.27 (0.55e3.05) 0.58 0.59 22 (64.7) 2.30 (0.46e11.60) 0.31
*p < 0.05 is considered statistically signiﬁcant.
aOR ¼ adjusted odds ratio; BMI ¼ body mass index; GWG ¼ gestational weight gain; IOM ¼ Institute of Medicine; RWG ¼ rate of weight gain.
a Reference GWG is obtained by 0.36e45 kg/wk multiplied by 28 weeks (0.36e45  28 ¼ 10.1e12.6).
b Reference GWG is obtained by 0.45e59 kg/wk multiplied by 28 weeks (0.45e59  28 ¼ 12.6e16.5).
c Reference GWG is obtained by 0.36e45 kg/wk multiplied by 16 weeks (0.36e45  16 ¼ 5.76e7.20).
d Reference GWG is obtained by 0.45e59 kg/wk multiplied by 16 wks (0.45e59  16 ¼ 7.20e9.44).
e Reference GWG is obtained by 0.36e45 kg/wk multiplied by 12 wks (0.36e45  12 ¼ 4.32e5.40).
f Reference GWG is obtained by 0.45e59 kg/wk multiplied by 12 weeks (0.45e59  12 ¼ 5.40e7.08).
g Reference GWG is obtained by 0.36e0.45 kg/wk multiplied by 8 weeks (0.36e45  8 ¼ 2.88e3.60).
h Reference GWG is obtained by 0.45e59 kg/week multiplied by 8 weeks (0.45e59  8 ¼ 3.60e4.72).
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13e16.5 kg during the 2nd and 3rd trimesters. The LBW ORs for
underweight women with GWG of 13 kg and of 16 kg were 6.12
(95% CI: 1.23e30.30) and 0.74 (95% CI: 0.11e5.23), respectively. For
normal weight women during the 2nd and 3rd trimesters, the LBW
OR for RWG of 0.36 kg/week was 1.99 (95% CI: 0.81e4.89) and of
0.45 kg/week was 1.26 (95% CI: 0.58e2.78). The LBW ORs for
underweight subjects during the 2nd and 3rd trimesters for RWG
values of 0.45 and of 0.59 kg/week were 5.35 (95% CI:
1.61e24.66) and 1.27 (95% CI: 0.23e6.95), respectively.
Examination of the IOM recommendations for underweight and
normal weight women for the 2nd and 3rd trimesters separately
We analyzed the GWG and RWG values separately for the 2nd
and 3rd trimesters in relation to their association with LBW. Weused the reference GWG with the recommended RWG multiplied
by 16 weeks for the 2nd trimester and the recommended RWG
multiplied by 12 weeks for the 3rd trimester (for normal weight
women: 6e7 kg in the 2nd trimester, 4e5 kg in the 3rd trimester;
for underweight women: 7e9 kg in the 2nd trimester, 5e7 kg in
the 3rd trimester). Among normal weight women, the LBW OR for
GWG values of 6 kg during the 2nd trimester was 3.49 (95% CI:
1.35e9.01) and of 7 kg during the 2nd trimester was 2.21 (95%
CI: 1.28e6.49). The LBW OR among normal weight women with a
RWG of 0.36 kg/week during the 2nd trimester was 3.39 (95% CI:
1.35e9.01) and of 0.45 kg/week during the 2nd trimester was
3.14 (95% CI: 1.32e7.47). During the 2nd trimester, the LBW ORs
for underweight women with a GWG of 7 kg and of 9 kg were
15.84 (95% CI: 2.46e101.99) and 2.06 (95% CI: 0.36e11.86),
respectively. Similarly, the LBW ORs for underweight subjects
with RWG of 0.45 kg/week and of 0.59 kg/week during the 2nd
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0.50e10.79), respectively. Among normal weight women, the
LBW OR for GWG values of 4 kg during the 3rd trimester was
1.56 (95% CI: 0.73e3.32) and of 5 kg during the 3rd trimester
was 1.09 (95% CI: 0.50e2.38). The LBW OR for RWG values of
0.36 kg/week during the 3rd trimester was 1.55 (95% CI:
0.68e3.49) and of 0.45 kg/week was 2.73 (95% CI: 0.60e2.70).
During the 3rd trimester, the LBW ORs for underweight women
with a GWG of 5 kg and of 7 kg were 0.96 (95% CI: 0.22e4.17)
and 0.77 (95% CI: 0.04e13.63), respectively. The LBW ORs for
underweight subjects during the 3rd trimester with a RWG of
0.45 kg/week and of 0.59 kg/week were 1.00 (95% CI: 0.24e0.41)
and 2.73 (95% CI: 0.25e29.60), respectively.Examination of the IOM recommendations for underweight and
normal weight women for 13e20 weeks of gestation and 21e28
weeks of gestation
We stratiﬁed the 2nd trimester into two periods: 13e20weeks of
gestation and 21e28 weeks of gestation. The reference GWG was
counted as the RWG multiplied by 8 weeks (for normal weight
women: 3e4 kg; for underweight women: 4e5 kg). Among normal
weight women, the LBW OR for GWG values of 3 kg for 13e20
weeks of gestationwas 2.60 (95% CI: 1.17e5.77), while that for GWG
values of 4 kg was 7.10 (95% CI: 2.25e22.42) and for GWG values
of5 kgwas 2.61 (95% CI: 0.66e10.27). The LBWOR for RWG values
of 0.36 kg/week for 13e20 weeks of gestation was 3.37 (95% CI:
1.50e7.61), while that for RWG values of 0.45 kg/week was 3.95
(95% CI: 1.67e9.38). For 21e28 weeks of gestation among normal
weight women, the LBWOR for GWG values of 3 kg was 1.22 (95%
CI: 0.49e3.07), while that for GWG values of 4 kg was 1.52 (95%
CI: 0.70e3.32) and that for GWG values of 5 kg was 0.78 (95% CI:
0.34e1.83). The LBWOR for RWG values of 0.36 kg/week was 1.33
(95% CI: 0.47e3.72) and RWG values of 0.45 kg/week was 1.27
(95% CI: 0.55e3.05). For underweight subjects during the period
13e20weeks of gestation, the LBWOR for GWG values of3 kgwas
1.04 (95% CI: 0.84e1.29), while that of 4 kg was 4.26 (95% CI:
0.69e26.20) and that of 5 kg was 2.76 (95% CI: 0.36e20.99). The
LBW OR for RWG values of 0.45 kg/week was 3.59 (95% CI:
0.79e16.31) and of 0.59 kg/week was 3.36 (95% CI: 0.52e21.66).
For underweight subjects during the period 21e28 weeks of
gestation, the LBW OR for GWG values of 3 kg could not be
calculated due to their small number, while that of 4 kg was 1.78
(95% CI: 0.39e8.13) and that of 5 kg was 2.76 (95% CI:
0.36e20.99). The LBWOR for RWG values of 0.45 kg/week duringTable 5
The adjusted (for age) ORs of LBW in terms of gestational weeks for all studied women (n
n (%)
All studied women (n ¼ 179)
Gestational weeks
37 weeks 144 (80.4)
38 weeks 84 (46.9)
39 weeks 42 (23.5)
40 weeks 13 (7.3)
Normal weight
n (%) OR (95% CI) p*
Gestational weeks
37 weeks 93 (80.9) 13.30 (3.65e48.46) <0
38 weeks 58 (50.4) 3.61 (1.66e7.87) 0
39 weeks 28 (24.3) 2.80 (1.08e7.26) 0
40 weeks 9 (7.8) 6.62 (0.80e54.81) 0
*p < 0.05 was considered statistically signiﬁcant.
CI ¼ conﬁdence interval; LBW ¼ low birth weight; OR ¼ odds ratio.the period 21e28 weeks of gestation was 13.02 (95% CI:
1.30e130.50), while that of 0.59 kg/week was 2.30 (95% CI:
0.46e11.60).
The LBW ORs of subjects with a gestation longer than 37 weeks
Table 5 shows that the LBWOR of all the studied subjects with a
gestational length 37 weeks to be 16.76 (95% CI: 4.90e57.34),
while that for38 weeks was 3.11 (95% CI: 1.69e5.73), that for39
weeks was 2.70 (95% CI: 1.29e5.63), and that for 40 weeks was
3.50 (95% CI: 0.93e13.17). Among normal weight women, the LBW
OR for gestation 37 weeks was 37.30 (95% CI: 3.65e48.46), while
that for 38 weeks was 3.61 (95% CI: 1.66e7.87), that for 39
weeks was 2.80 (95% CI: 1.08e7.26), and that for 40 weeks was 6.62
(95% CI: 0.80e54.81). Among underweight women, the LBWOR for
gestational week 37 weeks could not be calculated, while that for
38 weeks was 1.61 (95% CI: 0.41e6.24), that for 39 weeks was
2.17 (95% CI: 0.44e10.65), and that for 40 weeks was 0.86 (95% CI:
0.11e7.05).
Discussion
Adverse obstetrical outcomes in LBW subjects
Ehrenberg et al [12] indicated that LBW subjects had a low risk
of cesarean section. However, in our study, a higher cesarean rate
was seen for the LBW group. When the indications for cesarean
delivery were examined, eight out of 28 subjects received cesarean
section in the LBW group due to fetal distress, and there were no
such cases in the control group. Although most of the babies sur-
vived well with prompt management, this implies that a LBW fetus
and placenta is less able to tolerate labor, and the fetus needs
careful monitoring in such circumstances. Moreover, regardless of
the delivery mode, more newborns were sent to the NICU due to
asphyxia within 7 days of birth among the LBW group. Again, this
suggests that LBW fetuses are relatively vulnerable during the
neonatal period.
Following the recommendations of the IOM with respect to normal
weight and underweight women should reduce the risk of LBW
Our results show that normal weight and underweight women
who follow the recommendations of the IOM (2009) have a
reduced risk of LBW during their pregnancy. However, for under-
weight subjects, this must be cautiously approached because a¼ 179), for underweight women (n ¼ 34), and for normal weight women (n ¼ 115).






n (%) OR (95% CI) p*
.0001 30 (88.2) NA
.001 17 (50.0) 1.61 (0.40e6.24) 0.49
.03 9 (26.5) 2.17 (0.44e10.65) 0.34
.08 4 (11.8) 0.86 (0.11e7.05) 0.90
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ommendations seems to increase the risk of LBW. Women with a
total GWG 13 kg or a RWG during the 2nd and 3rd trimesters of
0.45 kg/week (the lower recommended range) still had a ﬁve-fold
increased risk of LBW (Table 4). The ﬁndings from the 2nd trimester
also show an increased risk in the lower range of the recommen-
dations for underweight women; however, during the 3rd trimester,
following the recommendations does not seem to increase the risk
of LBW. This suggests that underweight women need to stay in the
upper range of the recommendations for the 2nd trimester, which is
the time when gastroenteric symptoms induced by pregnancy
begin to subside [13].
In a Danish study, although they used the previous IOM (1990)
guidelines, they found that a GWG of more than 18 kg was able to
reduce the risk of low birth weight without a signiﬁcant increase in
macrosomia [14]. However, Stotland et al [8] revealed an associa-
tion between high weight gain above the IOM guidelines and
multiple adverse neonatal outcomes. The upper range of GWG
recommended by the IOM for underweight women is 18 kg;
therefore, we suggest that underweight women need to follow the
upper range of the IOM recommendations in order to prevent LBW
and neonatal adverse outcomes.
Normal weight women have to gain adequate weight during the
early half of the 2nd trimester
Table 4 shows that normal weight women with GWG and RWG
values within the reference IOM range for the 2nd trimester,
especially during weeks 13e20 of gestation, have a two-to three-
fold increased risk of LBW. However, during the other periods of
pregnancy, no such observation for normal weight women can be
identiﬁed. To explain the above observation, we need to examine
fetal growth physiology. Fetal growth can be viewed as having
three consecutive cell growth dynamic phases: the phase of a
rapid increase in cell number that occurs during the ﬁrst 16
weeks of gestation, the phase of concomitant cellular hyperplasia
and hypertrophy that occurs at mid-gestation and involves an
increase in both cell size and number and, ﬁnally, the phase of
rapid increase in cell size after 32 weeks of gestation [15e17]. It is
rational that inadequate nutrition during the cell hyperplasia
phase will result in a smaller body structure. Once a small body
structure is established, the growth size will be limited even if
sufﬁcient energy and oxygenation is supplied later in the preg-
nancy. However, the causes of LBW are multifactorial and include
both placental and maternal conditions. Placenta previa, placenta
vascular anomalies, maternal extreme malnutrition, vascular
disease, and renal disease will cause LBW [3]. In our study, the
above etiologies had been excluded. Another important feature of
this period of pregnancy is the formation of the placenta. The
mother provides nutrition and oxygenation to the fetus via the
placenta. It has been found that a small placenta size results in a
lower birth weight [3,18]. Our ﬁndings show the average size of
the placenta when there is LBW to be less than that of the control
groups (540.3 ± 115.5 g vs. 691.4 ± 155.9 g, p < 0.001, normal
weight women). The basic structure of the placenta is established
during the gestation period 13e20 weeks and therefore inade-
quate trophoblast invasion and spiral artery remodeling during
this period is likely to lead to poor placental perfusion and hyp-
oxia, which are believed to underlie LBW [3,19]. During this
important period, an inadequate nutrition supply is likely to in-
ﬂuence the size and structure of the placenta and thus fetal
growth. This ﬁnding suggests that it is important to carefully
monitor nutrition and weight gain among normal weight women
during the 2nd trimester, especially during weeks 13e20 of
gestation.Prolonged gestation is effective as a means of preventing LBW
among normal weight women, but is not effective among
underweight women
Table 5 shows that normal weight women who have a short
gestational period are at risk of LBW; however, if gestation is
prolonged beyond 37 weeks of pregnancy, this does not help
underweight women to avoid LBW. Normally, the fetus gains
weight at 5 g/day for the ﬁrst 15 weeks, at 15e20 g/day up to 24
weeks, and at 30e35 g/day up to 34 weeks of gestation [15,20].
Even during the last few weeks of gestation, fetal growth con-
tinues but only slowly. Thus it is logical that a longer gestation
ought to help to avoid LBW. However, there seems to be a differ-
ential effect of prolonged pregnancy with respect to preventing
LBW between the normal and underweight women. One sugges-
tion is that the functionality of the placenta during the last few
weeks of pregnancy is poorer among underweight women
compared to normal weight women. However, the exact mecha-
nism that causes the difference between normal and underweight
women needs further study. Nonetheless, these ﬁndings suggest
that it is ineffective to advise an underweight woman who is
suspected to be carrying a small-for-date fetus at 37 weeks of
gestation to prolong pregnancy.
In conclusion, women who delivered fetuses with LBW had a
2.5-fold increased risk of a cesarean delivery and a ﬁve-fold
increased risk of neonatal asphyxia within 7 days of birth. Among
underweight women, following the upper range of the IOM rec-
ommendations will reduce the risk of LBW. Among normal weight
women, following the recommended total GWG given by the IOM
should prevent LBW; however, it is suggested that, within the range
of the guidelines in the 2nd trimester (especially 13e20 weeks),
there may still be a two-to three-fold increased risk of LBW in
certain circumstances.Conﬂicts of interest
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